Lasa Health

What Lasa Health does

Lasa Health (legal entity Amie Health Inc., Delaware; HQ Boulder, Colorado) is a healthtech startup founded in 2022 by Margaret Melville and Chris Fortuna. The company develops an AI-powered patient engagement and clinical decision support platform targeting chronic pelvic pain (CPP) and endometriosis, conditions the company states affect up to 26% of women globally and 200 million people respectively, with typical diagnostic delays of 7-10+ years and a 75% misdiagnosis rate. Core products include the Lasa Health Platform (EHR-integrated AI screening and clinical decision support, including FHIR-integrated CDS for Epic), the LasaAI conversational chatbot (24/7 patient support), a mobile app for symptom tracking and individualized care plans, and an endometriosis assessment tool. The technology stack combines a proprietary ML screening ensemble trained on over 10 million patient records across 25+ CPP-related conditions, a custom data conversion tool, large language model-based conversational AI, and FHIR-based EHR integration.

The business operates a dual go-to-market model combining direct-to-consumer product-led growth (free LasaAI chatbot, freemium mobile app, and a paid Lasa Health Premium subscription with a one-week free trial) with enterprise field sales targeting healthcare providers and health systems via a 'Schedule a Demo' motion. Distribution is supported by content marketing (The Pelvic Edit blog), community engagement (monthly support groups, endometriosis awareness events), and clinical research (the EMMA Study funded by ARPA-H). Pricing is not publicly disclosed. The company is HIPAA-compliant, IRB-approved for clinical research, and is backed exclusively by non-dilutive grants (NSF SBIR Phase I, Colorado OEDIT, ARPA-H consortium) along with accelerator affiliations including Mayo Clinic Platform_Accelerate, StartUp Health, Techstars, and Springboard Enterprise. The platform currently serves the United States market and is not available in the European Union.

Name

Lasa Health

Legal name

Amie Health Inc.

Website

https://lasahealth.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

Lasa Health is a Boulder-based healthtech startup founded in 2022 that builds AI-powered screening, clinical decision support, and patient engagement tools for women with chronic pelvic pain and endometriosis, integrating with Epic EHR and serving both individual patients via a freemium app and providers via enterprise licensing.

Ownership category

akta.pro rank

Product category

Women's Health Software

NAICS

Custom Computer Programming Services (541511), Computer Systems Design and Related Services (54151)

SIC

Services-Health Services (8000), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Sexual & Pelvic Health Telehealth (STI care, pelvic pain, endometriosis/PCOS support) (HLALAHAJ)

akta.pro secondary industries

Care Navigation, Referral & Digital Front Door Platforms (HLALABAH), Patient Engagement, Education & Messaging Platforms (portal/CRM integrated) (HLALABAJ)

Keywords

• AI clinical decision support
• Chronic pelvic pain
• Women's health software
• EHR-integrated diagnostics
• Endometriosis management

Headquarters

HQ city

Boulder

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Patient Subscription (Lasa Health Premium): Patients can subscribe to Lasa Health Premium, which includes free access to the LasaAI chatbot and the mobile app. Subscriptions auto-renew indefinitely and can be cancelled prior to renewal. A one-week free trial is offered before charging.
2. Provider/Clinician Platform Licensing: The platform integrates into clinician EHR workflows. Providers can 'Schedule a Demo' suggesting B2B licensing of the platform to healthcare institutions. Revenue likely derives from per-provider or per-institution subscription fees.
3. Free Tier with Freemium Model: LasaAI chatbot is offered for free to patients using the Lasa Health platform. The assessment tool and basic app features are free. Premium features (Lasa Health Premium) are paid, with the EMMA Study providing free Premium access during the study period.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Lasa Health provides an AI/ML-driven patient engagement and clinical decision support platform for chronic pelvic pain and endometriosis. The platform integrates with electronic health records (EHRs) to screen for undiagnosed chronic pelvic pain patients using ML models covering 25+ conditions, and offers patients a 24/7 conversational chatbot (LasaAI), a mobile app for symptom tracking and flare management, and an endometriosis assessment tool. It sells to both individual patients (consumer subscription) and healthcare providers/health systems (EHR-integrated enterprise platform).

Product overview

Lasa Health offers an end-to-end patient engagement platform centered on chronic pelvic pain and endometriosis care. The core offering consists of the Lasa Health Platform (AI-powered screening and clinical decision support integrated with EHRs), the LasaAI chatbot (24/7 conversational support), the Mobile App (symptom tracking and flare management), and the Endometriosis Assessment Tool (AI-driven symptom evaluation). Supporting services include the EMMA Study (precision medicine research initiative), an online Support Group, and The Pelvic Edit educational blog. The platform is built on machine learning and NLP capabilities, integrating with Epic EHR and other electronic health record systems.

Differentiator

Problem solved

Functional benefit

Products and services

• Lasa Health Platform End-to-end patient engagement platform for chronic pelvic pain that integrates into clinicians' existing EHR workflows to facilitate provider-patient communication and improve time to diagnosis with embedded AI clinical decision support. Features AI-powered screening, comprehensive care management, and FHIR-integrated clinical decision support tools targeting OB/GYNs, pelvic floor therapists, and health systems.
• LasaAI 24/7 AI-powered conversational chatbot health assistant for women with chronic pelvic pain. Answers questions, suggests coping strategies, guides users through pain-reducing exercises (pelvic floor therapy, breathing exercises), and helps manage pain with therapeutic exercises and relaxation techniques. Built using conversational AI with large language models (LLMs) such as ChatGPT.
• Lasa Health Mobile App Mobile application for iOS/Android that creates individualized plans to help manage endometriosis and chronic pelvic pain, offering insights into symptoms, treatment options, and at-home flare-up strategies. Includes symptom tracking, pain management exercises, and access to the LasaAI chatbot.
• Endometriosis Assessment Tool AI-powered online assessment tool that helps users understand their symptoms related to endometriosis and chronic pelvic pain and provides guidance on next steps toward diagnosis. Available free of charge as part of the Lasa Health platform.

Quantifiable outcome

• Reduces diagnosis time for chronic pelvic pain from years to weeks
• +4 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability6 records

Feature5 records

Partnerships

Five partnerships are on record, tiered core and supporting.

• Nura HealthcoreStrategic or Co-development Partner · 1 October 2024Nura Health leads a consortium with Lasa Health and Dama Health awarded $3 million through ARPA-H's Sprint for Women's Health (spark track). The consortium aims to develop a comprehensive precision medicine platform for early endometriosis diagnosis and personalized treatment, combining non-invasive diagnostic tools, advanced patient phenotyping, and pharmacogenetics. Lasa Health contributes its AI-driven clinical decision support platform and patient engagement capabilities to the partnership.
• Dama HealthcoreStrategic or Co-development Partner · 1 October 2024Dama Health, an Illumina-backed healthtech company focused on precision medicine for hormone therapies, partners with Lasa Health as part of the ARPA-H Sprint for Women's Health consortium. Dama Health contributes phenotypic and genetic datasets for personalized treatment in endometriosis care.
• Mayo Clinic PlatformcoreStrategic or Co-development Partner · 1 May 2024Lasa Health was accepted into Mayo Clinic Platform_Accelerate, a 30-week accelerator program providing access to Mayo Clinic data and experts. Goals include enhancing ML models using Mayo's dataset, conducting clinical validation trials at Mayo Clinic and other institutions, and publishing peer-reviewed papers. Zoe Hsu is developing FHIR-integrated clinical decision support tools for Epic EHR integration.
• CEAPS (Center for Endometriosis and Advanced Pelvic Surgery)coreStrategic or Co-development Partner · 1 October 2023Lasa Health and CEAPS formed a strategic partnership to provide comprehensive endometriosis care from diagnosis to post-surgery recovery. CEAPS, with locations in Washington DC and Miami, provides laparoscopic excision surgery while Lasa Health supplies the patient engagement platform, provider-patient communication tools, and at-home support. Dr. Gaby Moawad, CEAPS founder, stated the partnership would leverage technology to offer comprehensive patient support.
• GuideasupportingTechnology or Integration · 1 August 2023Lasa Health partnered with Guidea, a digital health design agency led by CEO Theresa Neil, for the design and development of the AI-powered conversational chatbot for endometriosis flare-up support. Guidea provides UX/UI expertise and conversational AI design for the patient-facing chatbot product built with NSF SBIR funding.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Visana Health: Virtual-first women's health clinic treating complex conditions including endometriosis, PCOS, and menopause. Closest direct competitor to Lasa Health with overlapping focus on underserved women's conditions and a virtual care + provider model.
• Maven Clinic: Largest virtual clinic for women's and family health, covering fertility, pregnancy, postpartum, and menopause. Comparable to Lasa Health in offering women-specific virtual care, though broader and not endometriosis-specialized.
• Tia: Hybrid women's healthcare platform combining virtual and in-person care for gynecology, primary care, and mental health. Comparable business model of integrated women's health with clinical decision support principles applied at the practice level.
• Flo Health: Leading AI-driven women's health app for cycle tracking, symptoms, and education. Comparable to Lasa's consumer-facing app + AI chatbot offering, though Flo's focus is broader reproductive health rather than CPP-specific clinical decision support.

Emerging players

• Caraway Health: Virtual-first women's health startup focused on gen Z and millennial women, offering integrated mental, physical, and reproductive care. Comparable emerging player in the digital women's health space.
• Midi Health: Virtual care clinic for women in perimenopause and menopause. Comparable emerging virtual specialty women's health provider, though focused on midlife rather than pelvic pain.
• Elektra Health: Virtual platform for women in menopause combining tele-health visits, education, and community. Comparable in adjacent women's health vertical with virtual care plus community-led growth motions similar to Lasa's support groups.
• Mahmee: Maternal and infant health platform connecting parents with providers and support. Comparable emerging women's health platform with virtual care plus community engagement, though focused on the maternal journey rather than pelvic pain.

Broad incumbents

• Ro: Large direct-to-patient telehealth platform with women's health, men's health, and primary care verticals. A broader incumbent that could enter the endometriosis/pelvic pain space with substantially more capital and brand reach.
• Hims & Hers: Public, scaled D2C telehealth platform with growing women's health offerings. Broad incumbent that could leverage its brand and consumer funnel to expand into pelvic pain and endometriosis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lasa Health